Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis

J Autoimmun. 2024 Feb:143:103160. doi: 10.1016/j.jaut.2023.103160. Epub 2023 Dec 30.

Abstract

Autoimmune uveitis (AU) is a severe disorder causing poor vision and blindness. However, the cellular dynamics and pathogenic mechanisms underlying retinal injury in uveitis remain unclear. In this study, single-cell RNA sequencing of the retina and cervical draining lymph nodes in experimental autoimmune uveitis mice was conducted to identify the cellular spatiotemporal dynamics and upregulation of the glycolysis-related gene LDHA. Suppression of LDHA can rescue the imbalance of T effector (Teff) cells/T regulator (Treg) cells under inflammation via downregulation of the glycolysis-PI3K signaling circuit and inhibition of the migration of CXCR4+ Teff cells towards retinal tissue. Furthermore, LDHA and CXCR4 are upregulated in the peripheral blood mononuclear cells of Vogt-Koyanagi-Harada patients. The LDHA inhibitor suppresses CD4+ T cell proliferation in humans. Therefore, our data indicate that the autoimmune environment of uveitis regulates Teff cell accumulation in the retina via glycolysis-associated LDHA. Modulation of this target may provide a novel therapeutic strategy for treating AU.

Keywords: CXCR4 axis; Glycolysis; PI3K/AKT/FOXO1; Teff/treg; Uveitis.

MeSH terms

  • Animals
  • Autoimmune Diseases*
  • Humans
  • Leukocytes, Mononuclear
  • Mice
  • Phosphatidylinositol 3-Kinases
  • Retina
  • T-Lymphocytes, Regulatory
  • Uveitis*

Substances

  • Phosphatidylinositol 3-Kinases
  • LDHA protein, human